Articles Tagged With: nonmotor
-
Is Pimavanserin Safe to Use in Patients with Parkinson’s Disease?
This retrospective cohort study of patients with Parkinson’s disease ages 65 years or older residing in Medicare-certified long-term care facilities revealed pimavanserin use vs. nonuse is associated with an increased risk of 30-day hospitalization and higher 90-, 180-, and 365-day mortality.